Fit-for-purpose biomarker assays that connect mechanism, pharmacodynamics, safety, and patient stratification across preclinical and clinical development.
rebirthBiology supports singleplex and multiplex biomarker analysis with fit-for-purpose validation levels, matrix-specific performance review, and reporting aligned to exploratory or regulated objectives.
Platform and kit evaluation based on biology, matrix, sensitivity, dynamic range, and sample volume.
Precision, accuracy or relative accuracy, dilution linearity, selectivity, stability, and hook effect checks where relevant.
Cytokine, immune, inflammation, and pathway panels for translational and pharmacodynamic insights.
Development of tailored assays for novel targets, soluble proteins, and mechanism-specific readouts.
Validation depth is matched to exploratory, secondary, or pivotal biomarker use.
Interference, endogenous baselines, and sample handling variables are addressed early.
Outputs are organized for mechanism, exposure-response, and safety interpretation.
Send target markers, sample matrix, expected biology, and study endpoint role.
Discuss Biomarker Analysis